60 Degrees Pharmaceuticals, Inc. (SXTP)

NASDAQ: SXTP · USD

$0.86

+0.12 (+16.2%)· Recorded snapshot

Market cap	3M
Revenue (ttm)	1.2M
Net income (ttm)	-8.6M
EPS (ttm)	-$5.41
Shares out	3.5M
Volume	1,977,483
Beta	2.40

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 1.2M
Net income (ttm): -8.6M
EPS (ttm): -$5.41
Market cap: 3M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	احتفاظ

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-332.9

P25 n/aP50 n/aP75 n/a

ROIC-207.7

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All SXTP indicators

Market & fundamental data

Available fields

194

Groups with data

Currency

USD

Showing 194 of 194 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001946563
Company name	60 Degrees Pharmaceuticals, Inc.
Country	United States
Country code	US
CUSIP number	83006G500
Earnings date	2026-11-12
Employees	3
Employees change	1
Employees growth	50%
Enterprise value	$2.2M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2010
Industry	Biotechnology
IPO date	2023-07-12
Is primary listing	Yes
Is SPAC	No
ISIN number	US83006G5009
Last 10-K release date	2026-03-30
Last earnings date	2026-08-14
Last refreshed	2026-10-28
Last stock split date	2026-01-20
Last stock split type	Reverse
Market cap	$3M
Market cap category	Nano-Cap
Next earnings date	2026-11-12
Options	No
Price	$0.86
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	SXTP
Tags	pharmaceuticals
U.S. state	District of Columbia
Website	https://www.60degreespharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-629.12%
EV/Sales	1.7x
FCF / EV yield	-431.71%
FCF yield	-303.39%
Forward EV/Sales	1.39x
Forward P/S	1.98x
P/B ratio	1.16x
P/S ratio	2.41x
Sector forward P/E	23.56x
Sector P/E	50.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	-169.87%
Operating margin	-708.47%
Pretax margin	-667.68%
Profit per employee	$-2.9M
Revenue per employee	$404,977
ROA	-127.11%
ROA (5Y)	-72.85%
ROCE	-321.46%
ROE	-332.85%
ROIC	-207.72%
SBC / revenue	34.03%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	2
EPS growth years	3
Net income growth years	1
Revenue growth	23.41%
Revenue growth (Q)	-32.47%
Revenue growth (QoQ)	28.26%
Revenue growth 3Y	45.59%
Revenue growth years	2

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-119,880
Depreciation and amortization	$103,073
EBIT	$-8.6M
EBITDA	$-8.5M
EPS	$-5.41
FCF per share	$-2.53
Financing cash flow	$8.1M
Free cash flow	$-8.9M
Free cash flow minus SBC	$-9.3M
Gross profit	$-2.1M
Investing cash flow	$-288,342
Net cash flow	$-944,324
Net income	$-8.6M
Operating cash flow minus SBC	$-9.2M
Operating income	$-8.6M
Revenue	$1.2M
Stock-based compensation	$413,468

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-21.32
Book value per share	$-2.61
Debt / equity	0.06
Interest coverage	-274.33
Long-term assets	$551,397
Long-term liabilities	$149,176
Net cash (debt)	$871,427
Net cash / market cap	29.72%
Net cash growth	-51.93%
Net debt / equity	-0.34
Piotroski F-Score	2
Property, plant and equipment	$242,714
Shareholders' equity	$2.5M
Tangible book value	$-7.3M
Tangible book value per share	$-2.73
Total assets	$4.3M
Total cash	$1M
Total debt	$151,179
Total liabilities	$1.8M
WACC	17.38%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.29
Current assets	$3.7M
Current liabilities	$1.6M
Current ratio	2.32
Inventory turnover	3.91
Net working capital	$1.1M
Quick ratio	0.99
Working capital	$2.1M
Working capital turnover	0.57

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-506.6%
Dividend yield	0%
Shareholder yield	-506.6%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$1.36
1D price change	16.22%
1M price change	-28.8%
1M total return	-28.8%
1W price change	-9.67%
1W total return	-9.67%
1Y price change	-85.93%
1Y return CAGR	-85.95%
1Y total return	-85.93%
20-day SMA	$0.98
200-day SMA	$1.78
3M price change	-46.94%
3M total return	-46.94%
3Y price change	-99.47%
3Y return CAGR	-82.51%
3Y total return	-99.47%
50-day SMA	$1.02
50-day SMA vs 200-day SMA	50under200
52-week high	$8.62
52-week high date	2026-01-22
52-week low	$0.59
52-week low date	2026-10-27
6M price change	-48.58%
6M total return	-48.58%
All-time high	$2,076.00
All-time high date	2023-07-13
All-time low	$0.59
All-time low date	2026-10-27
Average true range (ATR)	$0.14
Average volume	1.1M
Beta (1Y)	1.56
Beta (2Y)	1.98
Beta (5Y)	2.4
Change from 52-week high	-90.02%
Change from 52-week low	46.26%
Change from all-time high	-99.96%
Change from all-time low	41.68%
Change from open	9.01%
Day's gap	6.61%
Dollar volume	$1.7M
High price	$0.98
Low price	$0.76
Monthly RSI	17.65
Open price	$0.79
Position in 52-week range	45.43%
Premarket change	6.08%
Premarket close	$0.74
Premarket price	$0.79
Premarket volume	244.5K
Previous close	$0.74
Price vs 150-day SMA	-38.84%
Price vs 20-day SMA	-14.58%
Price vs 200-day SMA	-53.3%
Price vs 50-day SMA	-18.17%
Relative volume	1.77
Return from IPO open	-99.91%
Return from IPO price	-84.27%
RSI	41.04
Sharpe ratio	-0.33
Sharpe ratio (3Y)	-0.48
Sortino ratio	-0.74
Sortino ratio (3Y)	-0.84
Volume	2M
Weekly RSI	35.18
YTD price change	-59.02%
YTD total return	-59.03%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	2.4M
Float percentage	69.53%
Shares change (QoQ)	53.78%
Shares change (YoY)	506.6%
Shares held by insiders	0.66%
Shares held by institutions	15.23%
Shares outstanding	3.5M
Short % of float	5.54%
Short % of shares	3.85%
Short ratio	1.7 days

Deeper analysis on SXTP

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this SXTP report

Is a complete SXTP research report available?

No complete published report is available for 60 Degrees Pharmaceuticals, Inc. (SXTP) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

60 Degrees Pharmaceuticals, Inc. (SXTP)

Price

Financial snapshot

Fair-value bridge

Latest news · SXTP

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All SXTP indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on SXTP

Frequently asked questions